NOVEL ANTI-HBV THERAPIES USING CRISPR/Cas9 TARGETING HBV GENOME STRONGLY SUPPRESS HBV.

Murai, K; Kodama, T; Hikita, H; Shimoda, A; Fukuoka, M; Fukutomi, K; Tahata, Y; Makino, Y; Yamada, R; Sakamori, R; Tatsumi, T; Takehara, T

HEPATOLOGY, 2020; 72 (): 61A

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索